BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  Advaxis, Inc. Engages SynCo Bio Partners B.V. For Manufacturing Of ADXS-HPV, Its Lead Cancer Immunotherapy Program

  February 11, 2014

   · 

  1 min read
• Business

  Sagent Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2013 Results

  February 11, 2014

   · 

  1 min read
• Pharm Country

  MYOS Board Of Directors Issues Letter To Shareholders

  February 11, 2014

   · 

  8 min read
• Business

  Medical Key Opinion Leaders In Preeclampsia Join Pluristem Therapeutics’s Steering Committee

  February 11, 2014

   · 

  1 min read
• Deals

  Biocept, Inc. Announces Closing Of Initial Public Offering

  February 11, 2014

   · 

  1 min read
• BioMidwest

  HTG Molecular Diagnostics, Inc. (Formerly Known as High Throughput Genomics, Inc.) Completes Initial Series E Preferred Stock Offering

  February 11, 2014

   · 

  1 min read
• Business

  Elite Pharmaceuticals, Inc. To Host Third Quarter Business Update Call On February 18, 2014

  February 11, 2014

   · 

  1 min read
• Drug Development

  Ultragenyx Pharmaceuticals Announces Initiation Of Phase 2 Study For Patients With Long-Chain Fatty Acid Oxidation Disorders

  February 11, 2014

   · 

  1 min read
• Business

  Spark Therapeutics Appoints Industry Leader Dr. Elliott Sigal, Former Executive Vice President And Chief Scientific Officer Of Bristol-Myers Squibb Company, To Board Of Directors

  February 11, 2014

   · 

  4 min read
• Drug Development

  Ario Pharma Commences Phase 2a Trial Of TRPV1 Inhibitor For Cough Associated With Chronic Obstructive Pulmonary Disease

  February 11, 2014

   · 

  1 min read